Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ketoprofen 10% gel
100302010AAACAC
|
Ketoprofen (Topical) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 100mg / Omeprazole 20mg modified-release capsules
1001010L0AAAMAM
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 100mg capsules
1001010L0AAABAB
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 100mg/2ml solution for injection ampoules
1001010L0AAAGAG
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 150mg modified-release capsules
1001010L0AAALAL
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 200mg / Omeprazole 20mg modified-release capsules
1001010L0AAANAN
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 50mg capsules
1001010L0AAAAAA
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketotard XL 200mg capsules
1001010L0BLAAAJ
|
Ketotard | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketovail 100mg modified-release capsules
1001010L0BEAAAI
|
Ketovail | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketovail 200mg modified-release capsules
1001010L0BEABAJ
|
Ketovail | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketozip 200 XL capsules
1001010L0BKAAAJ
|
Ketozip | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketpron XL 100mg capsules
1001010L0BPAAAI
|
Ketpron | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketpron XL 200mg capsules
1001010L0BPABAJ
|
Ketpron | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Kevzara 150mg/1.14ml inj pre-filled syringes
1001030ADBBAAAA
|
Kevzara | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Kevzara 150mg/1.14ml solution for injection pre-filled pens
1001030ADBBACAC
|
Kevzara | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Kevzara 200mg/1.14ml inj pre-filled syringes
1001030ADBBABAB
|
Kevzara | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Kevzara 200mg/1.14ml solution for injection pre-filled pens
1001030ADBBADAD
|
Kevzara | Sarilumab | Musculoskeletal and Joint Diseases | No data available |
|
Kineret 100mg/0.67ml inj pre-filled syringes
1001030R0BBAAAA
|
Kineret | Anakinra | Musculoskeletal and Joint Diseases | No data available |
|
Lamberts Vegan Glucosamine hydrochloride 660mg tablets
1001050A0CBABAR
|
Lambert's (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Lamberts Vegetarian Glucosamine hydrochloride 750mg tablets
1001050A0CBAAAB
|
Lambert's (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 300mg capsules
1001010F0BBAAAA
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 300mg tablets
1001010F0BBABAB
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 450mg tablets
1001010F0BBADAC
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederspan 100mg/5ml suspension for injection vials
1001022Y0BBACAC
|
Lederspan | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Lederspan 20mg/1ml suspension for injection vials
1001022Y0BBABAB
|
Lederspan | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.